On March 19, 2024, Elicio Therapeutics, Inc closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.98 USD | +5.70% | +1.01% | -4.32% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.32% | 80.3M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ELTX Stock
- News Elicio Therapeutics, Inc.
- Elicio Therapeutics, Inc. announced that it has received $5.999999 million in funding from Gkcc, LLC